Healthcare

Lundbeck to present comprehensive new bexicaserin dataset in patients with rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting

VALBY, Denmark, Dec. 2, 2025, 02:27 GMT-05

H-Lundbeck-A/S

Read full article →

Tata Elxsi, University of Illinois Urbana-Champaign, and OSF HealthCare Partner to Transform Rural Healthcare Access in the United States

BENGALURU, India and CHICAGO, Dec. 2, 2025, 02:23 GMT-05

TATA-ELXSI-Healthcare

Read full article →

Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health

LONDON, Dec. 2, 2025, 02:00 GMT-05

Accord-Plasma-Bone

Read full article →

Colorectal Cancer Market Set to Expand Throughout Forecast Period (2025-2034) Driven by Increasing Screening Rates and Novel Drug Approvals | DelveInsight

LAS VEGAS, Dec. 1, 2025, 17:31 GMT-05

DelveInsight-Business

Read full article →

Next-Generation Biologics and Biosimilars Market to Hit 251.13 billion Dollars by 2033 - Strategic Revenue Insights (SRI)

LONDON, Dec. 1, 2025, 12:51 GMT-05

SRI

Read full article →

Medical Adhesive Tapes Market Surges to USD 5.8 Billion by 2033, Propelled by 6.5% CAGR - Verified Market Reports®

LEWES, Del., Dec. 1, 2025, 11:55 GMT-05

Verified-Market-Repor

Read full article →

Cystic Fibrosis Therapeutics Market Set to Reach USD 35.09 Billion by 2033 as Precision CFTR Modulator Therapies Transform Patient Outcomes

AUSTIN, Texas and TOKYO, Dec. 1, 2025, 11:22 GMT-05

DataM-CF-Therapies

Read full article →

Smart Bed Market Set for Strong Growth as Connected Healthcare & Luxury Hospitality Drive Global Demand: Verified Market Research®

LEWES, Del., Dec. 1, 2025, 10:50 GMT-05

VERIFIEDMARKETRES

Read full article →

Respiratory Syncytial Virus Market to Reach USD 4.54 Billion by 2033 as Global Uptake of Next-Generation Vaccines & Monoclonal Antibodies Accelerates

AUSTIN, Texas and TOKYO, Dec. 1, 2025, 10:01 GMT-05

DATAM-INTELLIGENCE

Read full article →

Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe

DUBLIN and MUMBAI, India, Dec. 1, 2025, 09:34 GMT-05

GLENMARK-Cosmo

Read full article →

MediView Achieves First CE Mark, Bringing Augmented Reality to European Healthcare

CLEVELAND, Dec. 1, 2025, 08:00 GMT-05

MediView

Read full article →

Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI

SOMERVILLE, Mass., Dec. 1, 2025, 06:00 GMT-05

Generate:Biomedicines

Read full article →

Zentiva Expands into Biologics with the EU-Wide Launch of Its First Biosimilar

PRAGUE, Dec. 1, 2025, 04:00 GMT-05

Zentiva-Biosimilar

Read full article →

AbbVie to Present Phase 3 ECLIPSE Data Demonstrating Atogepant (AQUIPTA®) Superiority Over Placebo in Achieving Pain Freedom for the Acute Treatment of Migraine at the 19th European Headache Congress

NORTH CHICAGO, Ill., Dec. 1, 2025, 04:00 GMT-05

AbbVie-ECLIPSE-Data

Read full article →

Medical Membranes Market worth $6.66 billion by 2030 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Nov. 28, 2025, 10:30 GMT-05

MARKETSANDMARKETS

Read full article →

CRO Industry to Hit USD 127.77 Billion by 2030 Driven by Advanced Clinical Trial Models and Led by North America, Says Mordor Intelligence

HYDERABAD, India, Nov. 28, 2025, 05:46 GMT-05

MORDOR

Read full article →

Rhabdomyosarcoma Market is Expected to Rise Throughout Forecast Period (2025-2034) with Promising Drug Candidates in Pipeline | DelveInsight

LAS VEGAS, Nov. 27, 2025, 17:31 GMT-05

DELVEINSIGHT

Read full article →

Cosmetic Surgery Market is expected to generate a revenue of USD 71.33 Billion by 2031, Globally, at 3.50% CAGR: Verified Market Research®

LEWES, Del., Nov. 27, 2025, 10:50 GMT-05

Verified-Market

Read full article →

Pet DNA Testing Market to Reach $960.7 Million, Globally, by 2034 at 9.3% CAGR: Allied Market Research

WILMINGTON, Del., Nov. 27, 2025, 10:30 GMT-05

Allied-Market-Researc

Read full article →

Orphan Drugs Market to Surge to USD 486.51 Billion by 2032 as Rare Disease Innovation, Gene Therapies & Precision Medicine Reshape Global Healthcare

AUSTIN, Texas and TOKYO, Nov. 27, 2025, 10:01 GMT-05

DATAM-INTELLIGENCE

Read full article →